1. Cools M, Nordenström A, Robeva R, Hall J, Westerveld P, Flück C, et al. Caring for individuals with a difference of sex development (DSD): a consensus statement. Nat Rev Endocrinol. 2018 Jul;14(7):415–29.
2. Miller WL. The syndrome of 17, 20 lyase deficiency. J Clin Endocrinol Metab. 2012 Jan;97(1):59–67.
3. Geller DH, Auchus RJ, Mendonça BB, Miller WL. The genetic and functional basis of isolated 17, 20-lyase deficiency. Nat Genet. 1997 Oct;17(2):201–5.
4. Sherbet DP, Tiosano D, Kwist KM, Hochberg Z, Auchus RJ. CYP17 mutation E305G causes isolated 17, 20-lyase deficiency by selectively altering substrate binding. J Biol Chem. 2003 Dec;278(49):48563–9.
5. Hershkovitz E, Parvari R, Wudy SA, Hartmann MF, Gomes LG, Loewental N, et al. Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17, 20-lyase deficiency. J Clin Endocrinol Metab. 2008 Sep;93(9):3584–8.